Implications of altered Na+-K+-adenosine triphosphatase in hypertension accompanying early stage kidney disease.
Schiffl
H
H
Department of Internal Medicine, University of Munich, Germany.
Küchle
C
C
Lang
S
S
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D000252:Calcium-Transporting ATPases / Q000502:physiology; D027682:Cation Transport Proteins; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000150:complications / Q000188:drug therapy / Q000201:enzymology* / Q000503:physiopathology; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy / Q000201:enzymology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology
D027682:Cation Transport Proteins; D004232:Diuretics; D000251:Adenosine Triphosphatases; C022761:potassium transporting ATPase; C021838:sodium-translocating ATPase; D000252:Calcium-Transporting ATPases; D000254:Sodium-Potassium-Exchanging ATPase